Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870296 · ClinicalTrials.gov registry record · NA
Anticoagulation Medical Home
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
NCT02870296 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 162 participants.
The verdict
NCT02870296, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
Study Summary
The primary study goal is to improve the quality of care transitions for patients with new episodes of venous thromboembolism (VTE). Primary Outcomes: To measure differences in the quality of care transition, as measured by the Care Transition Measure (CTM)-15 in the investigators target population of patients with incident VTE randomized to either a multicomponent, anticoagulation medical home intervention or usual care. Secondary Major Outcomes: To measure the difference in recurrent VTE, major hemorrhage, all-cause re-admissions, and mortality between the investigators intervention and comparison groups at 30 and 90 days in the investigators target population. Secondary Other Outcomes: To measure patient knowledge, health-related quality of life, and time in the therapeutic range (TTR) for patients on warfarin in the investigators target population.
Interventions
- BEHAVIORAL Enhanced Assessment and Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2016-10-21 |
| Est. Completion | 2018-01-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02870296
The ClinicalTrials.gov registry entry for NCT02870296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced Assessment and Education is the first listed.
NCT02870296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02870296 about?
NCT02870296 is a clinical study titled "Anticoagulation Medical Home". The primary study goal is to improve the quality of care transitions for patients with new episodes of venous thromboembolism (VTE). Primary Outcomes: To measure differences in the quality of care transition, as measured by the Care Transition Measure (CTM)-15 in the investigators target population...
What is the current status of trial NCT02870296?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2016-10-21. Estimated completion is 2018-01-05.
What interventions are being tested in trial NCT02870296?
The interventions under investigation include: Enhanced Assessment and Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02870296?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.